Prevalence of pelvic floor disorders in the Eastern Mediterranean region

References

1. 1.↵
   1. Dheresa M,
   2. Worku A,
   3. Oljira L,
   4. Mengiste B,
   5. Assefa N,
   6. Berhane Y.

   One in five women suffer from pelvic floor disorders in Kersa district Eastern Ethiopia: a community-based study. BMC Womens Health 2018; 18: 95.

   OpenUrl
2. 2.↵
   1. Alshenqeti AM,
   2. Almutairi RE,
   3. Keram AM.

   Impact of Urinary Incontinence on Quality of Life Among Women of Childbearing Age in Al Madinah Al Munawara, Saudi Arabia. Cureus 2022; 10; 14: e24886.

   OpenUrl
3. 3.↵
   1. Verbeek M,
   2. Hayward L.

   Pelvic floor dysfunction and its effect on quality of sexual life. Sex Med Rev 2019; 7: 559–564.

   OpenUrl
4. 4.↵
   1. Ghandour L,
   2. Minassian V,
   3. Al-Badr A,
   4. Abou Ghaida R,
   5. Geagea S,
   6. Bazi T.

   Prevalence and degree of bother of pelvic floor disorder symptoms among women from primary care and specialty clinics in Lebanon: an exploratory study. Int Urogynecol J 2017; 28: 105–118.

   OpenUrl
5. 5.↵
   1. Lopes LG,
   2. Vasconcelos CTM,
   3. Neto JAV,
   4. Oriá MOB,
   5. Saboia DM,
   6. Gomes MLS, et al.

   A systematic review of the prevalence, risk factors, and impact of pelvic floor dysfunctions in nurses. Neurourol Urodyn 2019; 38: 1492–503.

   OpenUrl
6. 6.
   1. AlShami HA,
   2. Kadasne AR,
   3. Khalfan M,
   4. Iqbal SZ,
   5. Mirghani HM.

   Pregnancy outcome in late maternal age in a high-income developing country. Arch Gynecol Obstet 2011; 284: 1113–1116.

   OpenUrlPubMed
7. 7.↵
   1. Elbiss HM,
   2. Osman N,
   3. Hammad FT.

   Social impact and healthcare-seeking behavior among women with urinary incontinence in the United Arab Emirates. Int J Gynaecol Obstet 2013; 122: 136–139.

   OpenUrl
8. 8.↵
   1. Moher D,
   2. Shamseer L,
   3. Clarke M,
   4. Ghersi D,
   5. Liberati A,
   6. Petticrew M, et al.

   Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. BMJ; 4: 1–9.
9. 9.↵
   World Health Organization. Countries included in the Eastern Mediterranean Region 2022. [Updated 2023; Accessed 2022 June 1]. Available from: http://www.emro.who.int/countries.html
10. 10.↵
    1. Martin J.

    © Joanna Briggs Institute 2017 Critical Appraisal Checklist for Prevalence Studies. Published online. 2017;7.
11. 11.↵
    1. Al-Badr A,
    2. Saleem Z,
    3. Kaddour O,
    4. Almosaieed B,
    5. Dawood A,
    6. Al-Tannir

    . Prevalence of pelvic floor dysfunction: A Saudi National survey. BMC Womens Health 2022; 22: 27.

    OpenUrl
12. 12.↵
    1. Direkvand-Moghadam A,
    2. Ghazanfari Z,
    3. Sayehmiri K.

    Predictive factors for pelvic organ prolapse (POP) in Iranian women’s: an ordinal logistic approch. Journal of clinical and diagnostic research. J Clin Diagn Res 2014; 8: 96–99.

    OpenUrl
13. 13.↵
    1. Talab S,
    2. Al‐Badr A,
    3. AlKusayer GM,
    4. Dawood A,
    5. Bazi T.

    Correlates of vaginal laxity symptoms in women attending a urogynecology clinic in Saudi Arabia. IInt J Gynaecol Obstet 2019;145: 278–282.

    OpenUrl
14. 14.↵
    1. Elbiss HM,
    2. Osman N,
    3. Hammad FT.

    Prevalence, risk factors and severity of symptoms of pelvic organ prolapse among Emirati women. BMC urology 2015; 15: 1–5.

    OpenUrl
15. 15.↵
    1. Amin A,
    2. Ali A,
    3. Amin Z,
    4. Sani FN.

    Justification for hysterectomies and frequency of histopathological lesions of hysterectomy at a Teaching Hospital in Peshawar, Pakistan. Pak J Med Sci 2013; 29: 170.

    OpenUrl
16. 16.↵
    1. Ahmed A-fA-m,
    2. Solyman AA-k,
    3. Kamal SM.

    Potential host-related risk factors for recurrent urinary tract infection in Saudi women of childbearing age. Int Urogynecol J 2016; 27: 1245–1253.

    OpenUrl
17. 17.↵
    1. Awwad J,
    2. Sayegh R,
    3. Yeretzian J,
    4. Deeb ME.

    Prevalence, risk factors, and predictors of pelvic organ prolapse: a community-based study. Menopause 2012; 19: 1235–1241.

    OpenUrlCrossRefPubMed
18. 18.↵
    1. Al-Shaikh GK,
    2. Ibrahim L,
    3. Al-Mandeel H,
    4. Alshaikh R,
    5. Syed SB.

    Association of obesity with pelvic floor disorders and its effect on the quality of life in women awaiting bariatric surgery. Kuwait Med J 2018; 50: 461–466.

    OpenUrl
19. 19.↵
    1. Ambreen A,
    2. Anwer K,
    3. Intsar A,
    4. Khurshid S.

    Clinical audit on hysterectomy for year 2011 in fatima memorial hospital lahore. Ann King Edw Med Univ 2013; 19: 186.

    OpenUrl
20. 20.↵
    1. Jokhio AH,
    2. Rizvi RM,
    3. MacArthur C.

    Prevalence of pelvic organ prolapse in women, associated factors and impact on quality of life in rural Pakistan: population-based study. BMC Women’s Health 2020; 20: 1–7.

    OpenUrlPubMed
21. 21.↵
    1. Hakimi S,
    2. Aminian E,
    3. Alizadeh Charandabi SM-,
    4. Bastani P,
    5. Mohammadi M.

    Risk factors of overactive bladder syndrome and its relation to sexual function in menopausal women. Urologia 2018; 85: 10–4.

    OpenUrl
22. 22.↵
    1. Sami N,
    2. Ali TS,
    3. Osama M.

    Quality of life among women with symptoms of gynecological morbidities: Results of a cross‐sectional study in K arachi, P akistan. J Obstet Gynaecol Res 2015; 41: 608–614.

    OpenUrl
23. 23.↵
    1. Page MJ,
    2. McKenzie JE,
    3. Bossuyt PM,
    4. Boutron I,
    5. Hoffmann TC,
    6. Mulrow CD, et al.

    The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372.
24. 24.↵
    1. Beketie ED,
    2. Tafese WT,
    3. Assefa ZM,
    4. Berriea FW,
    5. Tilahun GA,
    6. Shiferaw BZ, et al.

    Symptomatic pelvic floor disorders and its associated factors in South-Central Ethiopia. PloS One 2021; 16: e0254050.

    OpenUrl
25. 25.↵
    1. de Freitas LM,
    2. Bø K,
    3. Fernandes ACNL,
    4. Uechi N,
    5. Duarte TB,
    6. Ferreira CHJ.

    Pelvic floor muscle knowledge and relationship with muscle strength in Brazilian women: a cross-sectional study. Int Urogynecol J 2019; 30: 1903–1909.

    OpenUrl
26. 26.↵
    1. Gedefaw G,
    2. Demis A.

    Burden of pelvic organ prolapse in Ethiopia: a systematic review and meta-analysis. BMC Women’s Health 2020; 20: 1–9.

    OpenUrlPubMed
27. 27.↵
    1. Islam RM,
    2. Oldroyd J,
    3. Rana J,
    4. Romero L,
    5. Karim MN.

    Prevalence of symptomatic pelvic floor disorders in community-dwelling women in low and middle-income countries: a systematic review and meta-analysis. Int Urogynecol J 2019; 30: 2001–2011.

    OpenUrl
28. 28.
    1. Mou T,
    2. Warner K,
    3. Brown O,
    4. Yeh C,
    5. Beestrum M,
    6. Kenton K, et al.

    Prevalence of pelvic organ prolapse among US racial populations: A systematic review and meta‐analysis of population‐based screening studies. Neurourol Urodyn 2021.
29. 29.↵
    1. Bland DR,
    2. Earle BB,
    3. Vitolins MZ,
    4. Burke G.

    Use of the pelvic organ prolapse staging system of the International Continence Society, American Urogynecologic Society, and Society of Gynecologic Surgeons in perimenopausal women. Am J Obstet Gynecol 1999; 181: 1324–1328.

    OpenUrlPubMed
30. 30.
    1. Baden W,
    2. Walker T,
    3. Lindsey J.

    The vaginal profile. Tex Med 1968; 64: 56–58.

    OpenUrlPubMed
31. 31.
    1. Persu C,
    2. Chapple C,
    3. Cauni V,
    4. Gutue S,
    5. Geavlete P.

    Pelvic Organ Prolapse Quantification System (POP–Q)–a new era in pelvic prolapse staging. J Med Life 2011; 4: 75.

    OpenUrlPubMed
32. 32.↵
    1. Aoki Y,
    2. Brown HW,
    3. Brubaker L,
    4. Cornu JN,
    5. Daly JO,
    6. Cartwright R.

    Urinary incontinence in women. Nat Rev Dis Primers 2017; 3: 1–20.

    OpenUrl